France · Series B startup

Who invested in nextProtein

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Agtech

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $21MNov 2025
Investors
5
See who backed them

The rounds

  1. Nov 2025

Founders and team

From nextProtein's own website: 2 founders.

Mohamed GastliFounder & CEO
Syrine ChaalalaFounder & COO

Everyone who backed them

Kima VenturesVC firm1round
Societe GeneraleCorporate VC1round
Swen Capital PartnersAsset manager1round
MirovaPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists nextProtein as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Stellar ImpactInvestment firmPer its own site

Quick answers about nextProtein

Who invested in nextProtein?

nextProtein's investors include Kima Ventures, Societe Generale, British International Investment, Swen Capital Partners and Mirova.

How much has nextProtein raised?

nextProtein has raised $21M across 1 round since 2025.

When did nextProtein last raise?

nextProtein's most recent round was a Series B of $21M in Nov 2025.

What was nextProtein's biggest round?

Its most recent round, $21M in Nov 2025, is also its largest on record.

Who backed nextProtein first?

nextProtein's first round on record, in Nov 2025, was backed by Kima Ventures, Societe Generale and British International Investment and 2 others.

What stage is nextProtein at?

nextProtein's latest named round is a Series B, in Nov 2025.

Where is nextProtein based?

nextProtein is based in France.

Companies like nextProtein

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.